 | Up a level |
Du Puy, R S; Postmus, I; Stott, D J; Blum, Manuel; Poortvliet, R K E; Den Elzen, W P J; Peeters, R P; van Munster, B C; Wolffenbuttel, B H R; Westendorp, R G J; Kearney, P M; Ford, I; Kean, S; Messow, C M; Watt, T; Jukema, J W; Dekkers, O M; Smit, J W A; Rodondi, Nicolas; Gussekloo, J; ... (2018). Study protocol: a randomised controlled trial on the clinical effects of levothyroxine treatment for subclinical hypothyroidism in people aged 80 years and over. BMC Endocrine Disorders, 18(1), p. 67. BioMed Central 10.1186/s12902-018-0285-8
Segna, D; Bauer, D C; Feller, M; Schneider, C; Fink, H A; Aubert, C E; Collet, T-H; Da Costa, B R; Fischer, K; Peeters, R P; Cappola, A R; Blum, M; van Dorland, H A; Robbins, J; Naylor, K; Eastell, R; Uitterlinden, A G; Rivadeneira Ramirez, F; Gogakos, A; Gussekloo, J; ... (2018). Association between subclinical thyroid dysfunction and change in bone mineral density in prospective cohorts. Journal of internal medicine, 283(1), pp. 56-72. Blackwell Scientific Publications 10.1111/joim.12688
Chaker, L; Korevaar, T I M; Rizopoulos, D; Collet, T-H; Völzke, H; Hofman, A; Rodondi, Nicolas; Cappola, A R; Peeters, R P; Franco, O H (2017). Defining optimal health range for thyroid function based on the risk of cardiovascular disease. Journal of clinical endocrinology and metabolism, 102(8), pp. 2853-2861. Endocrine Society 10.1210/jc.2017-00410
